COLLATERAL THERAPEUTICS INC
10-Q, EX-27.1, 2000-07-28
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: COLLATERAL THERAPEUTICS INC, 10-Q, 2000-07-28
Next: CORVIS CORP, S-1, 2000-07-28



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                      17,196,080
<SECURITIES>                                17,215,728
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            34,909,018
<PP&E>                                       4,516,016
<DEPRECIATION>                               1,749,820
<TOTAL-ASSETS>                              37,958,200
<CURRENT-LIABILITIES>                        3,041,219
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        13,036
<OTHER-SE>                                  34,496,537
<TOTAL-LIABILITY-AND-EQUITY>                37,958,200
<SALES>                                              0
<TOTAL-REVENUES>                             1,406,205
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             8,972,893
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              54,632
<INCOME-PRETAX>                            (6,461,778)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (6,461,778)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (6,461,778)
<EPS-BASIC>                                     (0.50)
<EPS-DILUTED>                                   (0.50)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission